黄体初期短程应用米非司酮治疗子宫内膜异位症37例疗效分析被引量：15

导出

摘要目的探索在不影响月经周期的情况下小剂量短程应用米非司酮治疗子宫内膜异位症的疗效。方法2004-09-2005-09武汉市中心医院对37例临床主要表现为中重度痛经的子宫内膜异位症患者(重度14例、中度23例),于每次月经第14天开始每日1次米非司酮片剂6.25mg连服4d,连续6个月经周期观察经期痛经程度及月经量的变化。结果除2例月经曾分别推迟1个月和闭经3个月外其余月经周期正常。37例在6个用药周期中共有94例次(42.34%)痛经完全消失,91例次(40.99%)减轻,37例次(16.67%)无效;痛经症状治疗总有效率为83.33%。痛经减轻时月经量亦有明显改善,但异位内膜囊肿大小变化不明显。结论月经黄体初期短程应用小剂量米非司酮可在不影响月经周期的情况下对子宫内膜异位症痛经症状有较好的治疗作用。

作者周青松

机构地区武汉市中心医院妇产科

出处《中国实用妇科与产科杂志》 CAS CSCD 北大核心 2006年第9期702-703,共2页 Chinese Journal of Practical Gynecology and Obstetrics

关键词子宫内膜异位症米非司酮痛经

分类号 R71 [医药卫生—妇产科学]

作者简介 E—mail：guten2000cn@yahoo．com．cn

引文网络
相关文献

参考文献11

1Kettel LM,Murphy AA,Morales AJ,et al.Preliminary report on the treatment of endometriosis with low-dose mifepristone (RU 486)[J].Am J Obstet Gynecol,1998,178(6):1151-1156.
2Jiang J,Wu RF,Wang ZH,et al.Effect of mifepristone on estrogen and progesterone receptors in human endometrial and endometriotic cells in vitro[J].Fertil Steril,2002,77 (5):995-1000.
3陈杰,潘晓玲.子宫内膜异位症的药物治疗进展[J].现代预防医学,2004,31(2):216-218. 被引量：17
4李萍,张爱武,殷蕙蓉,史承明.米非司酮治疗子宫内膜异位症疗效及对性激素的影响[J].江苏医药,2004,30(3):200-201. 被引量：12
5Kettel LM,Murphy AA,Morales AJ,et al.Treatment of endometriosis with the antiprogesterone mifepristone (RU486)[J].Fertil Steril,1996,65(1):23-28.
6刘英,王宇,李梅.小剂量米非司酮治疗子宫内膜异位症的临床观察[J].西南国防医药,2004,14(1):47-49. 被引量：16
7Spitz IM,Grunberg SM,Chabbert-Buffet N,et al.Management of patients receiving long-term treatment with mifepristone[J].Fertil Steril,2005,84(6):1719-1726.
8Nayak NR,Ghosh D,Sengupta J.Effect of luteal phase administration of mifepristone (RU486) and prostaglanding analogue or inhibitor on endometrium in the rhesus monkey[J].Hum Reprod,1998,13(4):1047-1056.
9朱顺法 ,方马荣 ,金理正 .长期应用小剂量米非司酮对子宫内膜形态功能和雌孕激素受体的影响[J].卫生职业教育,2004,22(8):105-107. 被引量：14
10Croxatto HB,Salvatierra AM,Croxatto HD,et al.Effects of continuous treatment with low dose mifepristone throughout one menstrual cycle[J].Hum Reprod,1993,8(2):201-207.

二级参考文献28

1朱四军,赵白鸽,谢衷明.RU486对下丘脑－垂体－卵巢－子宫内膜轴的功能影响[J].生殖与避孕,1995,15(4):243-248. 被引量：299
2朱关珍,杜明昆,郑惠娥,李瑞琴,陆勇娟,金毓翠.丹那唑栓治疗子宫内膜异位症的临床研究[J].中国实用妇科与产科杂志,1995,11(4):225-226. 被引量：17
3[2]Yamamoto T, Noguchi T, Tamura T, et al. Evidence for estrogen synthesis in adenomyotic tissues [J] . Am J Obstet Gynecol,1993, 169: 734.
4[3]Carpenter SE,Tjaden B,Rock JA,et al. The effect of regular exercise on women receiving danazol for treatment of endometriosis[J]. Int J Gynaecol Obstet, 1995 Jun;49(3):299-304.
5[4]Igarashi M, Iizuka M, Abe Y, et al. Novel vaginal danazol ring therapy for pelvic endometriosis, in particular deeply infiltrating endometriosis [J]. Hum Reprod, 1998 Jul ; 13 (7): 1952-1956.
6[8]Kettel LM, Murphy AA, Morales AJ, et al. Treatment of endometriosis with the antiprogesterone mifepristone (RU486)[J].FertilSteril, 1996Jan; 65 (1): 23-28.
7[11]Sillem M, Parviz M, Woitge HW, et al. Add-back medrogestone does not prevent bone loss in premenopausal women treated with goserelin [J] . Exp Clin Endocrinol Diabetes, 1999, 107(6) : 379-385.
8[12]Gargiulo AR, Hornstein MD. The role of GnRH agonists plus add-back therapy in the treatment of endometriosis [ J] . Semin Reprod Endocrinol, 1997; 15 (3): 273-84. Review.
9[13]Freundl G, Godtke K, Gnoth C, et al. Steroidal 'add-back'therapy in patients treated with GnRH agonists [J ]. Gynecol Obstet Invest, 1998; 45 Suppl 1: 22-30; discussion 35.
10[14]Klauber N, Rohan RM, Flynn E, et al. Critical components of the female reproductive pathway are suppressed by the angiogenesis inhibitor AGM-1470 [J] . Nat Med. 1997 Apr; 3 (4) :443-6.